Skip to main content
Erschienen in: Annals of Surgical Oncology 12/2018

13.08.2018 | Gynecologic Oncology

Minority Race Predicts Treatment by Non-gynecologic Oncologists in Women with Gynecologic Cancer

verfasst von: Amin A. Ramzan, MD, Kian Behbakht, MD, Bradley R. Corr, MD, Jeanelle Sheeder, MSPH, PhD, Saketh R. Guntupalli, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Outcomes of women with gynecologic cancer are superior when treated by gynecologic oncologists. The National Surgical Quality Improvement Program (NSQIP) began identifying gynecologic surgeon subspecialty in 2014. We sought to identify characteristics and outcomes of women treated by general gynecologists in comparison with women treated by gynecologic oncologists.

Patients and Methods

Patients undergoing hysterectomy for gynecologic malignancy in 2014 and 2015 were abstracted from the NSQIP database. Patient characteristics, morbidities, surgeon specialty, and operative outcomes were captured.

Results

7271 hysterectomies were performed for malignant disease, and 669 were performed by generalists. In comparison with generalists, gynecologic oncologists operated on patients who were older (P < 0.001), more likely to be White [odds ratio (OR) 2.1, P < 0.001], had disseminated cancer (OR 3.1, P < 0.001), had ascites (OR 2.6, P < 0.001), and were classified as American Society of Anesthesiologists (ASA) class ≥ 3 (OR 1.7, P < 0.001). Gynecologic oncologists were also more likely to have hospital readmissions (OR 1.7, P = 0.004) and perform lymph node dissections for endometrial cancer (OR 2.2, P < 0.001). On multivariable analysis, older age [adjusted OR (aOR) 1.0, P = 0.021], White race (aOR 2.0, P < 0.001), presence of disseminated cancer (aOR 2.5, P < 0.001), presence of ascites (aOR 1.8, P = 0.036), and ASA class ≥ 3 (aOR 1.6, P < 0.001) remained independent predictive factors for having a gynecologic oncology surgeon.

Conclusions

The majority of gynecologic cancer cases are performed by gynecologic oncologists. Generalists are more likely to operate on minority patients and patients with fewer comorbidities. Further efforts to ensure access to specialized cancer care for all patients are needed.
Literatur
1.
Zurück zum Zitat Practice bulletin no. 149: endometrial cancer. Obstet Gynecol. 2015;125(4):1006–26.CrossRef Practice bulletin no. 149: endometrial cancer. Obstet Gynecol. 2015;125(4):1006–26.CrossRef
2.
Zurück zum Zitat Practice bulletin no. 174: evaluation and management of adnexal masses. Obstet Gynecol. 2016;128(5)e210–26.CrossRef Practice bulletin no. 174: evaluation and management of adnexal masses. Obstet Gynecol. 2016;128(5)e210–26.CrossRef
3.
Zurück zum Zitat Bristow RE, et al. Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet Gynecol. 2013;121(6):1226–34.CrossRefPubMed Bristow RE, et al. Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet Gynecol. 2013;121(6):1226–34.CrossRefPubMed
4.
Zurück zum Zitat Bristow RE, et al. Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes. Gynecol Oncol. 2009;115(3):334–8.CrossRefPubMed Bristow RE, et al. Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes. Gynecol Oncol. 2009;115(3):334–8.CrossRefPubMed
6.
Zurück zum Zitat Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–4.CrossRefPubMed Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–4.CrossRefPubMed
7.
8.
Zurück zum Zitat Wallace AH, et al. Projecting the need for gynecologic oncologists for the next 40 years. Obstet Gynecol. 2010;116(6):1366–72.CrossRefPubMed Wallace AH, et al. Projecting the need for gynecologic oncologists for the next 40 years. Obstet Gynecol. 2010;116(6):1366–72.CrossRefPubMed
9.
Zurück zum Zitat Chan JK, et al. Influence of gynecologic oncologists on the survival of patients with endometrial cancer. J Clin Oncol. 2011;29(7):832–8.CrossRefPubMed Chan JK, et al. Influence of gynecologic oncologists on the survival of patients with endometrial cancer. J Clin Oncol. 2011;29(7):832–8.CrossRefPubMed
10.
Zurück zum Zitat Chan JK, et al. Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Obstet Gynecol. 2007;109(6):1342–50.CrossRefPubMed Chan JK, et al. Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Obstet Gynecol. 2007;109(6):1342–50.CrossRefPubMed
11.
Zurück zum Zitat Wright JD, et al. Patterns of specialty-based referral and perioperative outcomes for women with endometrial cancer undergoing hysterectomy. Obstet Gynecol. 2017;130(1):81–90.CrossRefPubMedPubMedCentral Wright JD, et al. Patterns of specialty-based referral and perioperative outcomes for women with endometrial cancer undergoing hysterectomy. Obstet Gynecol. 2017;130(1):81–90.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1): 5–29.CrossRefPubMed Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1): 5–29.CrossRefPubMed
19.
Zurück zum Zitat Chatterjee S. et al. Disparities in gynecological malignancies. Front Oncol. 6:36. Chatterjee S. et al. Disparities in gynecological malignancies. Front Oncol. 6:36.
20.
Zurück zum Zitat Kohler BA, et al. Annual report to the nation on the status of cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst. 2015;107(6):djv048. Kohler BA, et al. Annual report to the nation on the status of cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst. 2015;107(6):djv048.
21.
Zurück zum Zitat GoffBA, et al. Predictors of comprehensive surgical treatment in patients with ovarian cancer. Cancer. 2007;109(10):2031–42.CrossRefPubMed GoffBA, et al. Predictors of comprehensive surgical treatment in patients with ovarian cancer. Cancer. 2007;109(10):2031–42.CrossRefPubMed
22.
Zurück zum Zitat Wright J, et al. Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival. Br J Cancer. 2008;98(7):1197–203.CrossRefPubMedPubMedCentral Wright J, et al. Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival. Br J Cancer. 2008;98(7):1197–203.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Bristow RE, et al. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status. J Natl Cancer Inst. 2013;105(11):823–32.CrossRefPubMedPubMedCentral Bristow RE, et al. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status. J Natl Cancer Inst. 2013;105(11):823–32.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Mukherjee D, et al. Disparities in access to neuro-oncologic care in the United States. Arch Surg. 2010;145(3):247–53.CrossRefPubMed Mukherjee D, et al. Disparities in access to neuro-oncologic care in the United States. Arch Surg. 2010;145(3):247–53.CrossRefPubMed
25.
Zurück zum Zitat Morris AM et al. Racial disparities in late survival after rectal cancer surgery. J Am Coll Surg. 2006;203(6): 787–94.CrossRefPubMed Morris AM et al. Racial disparities in late survival after rectal cancer surgery. J Am Coll Surg. 2006;203(6): 787–94.CrossRefPubMed
26.
Zurück zum Zitat Pollack CE, et al. Racial disparities in changing to a high-volume urologist among men with localized prostate cancer. Med Care. 2011;49(11):999–1006.PubMedPubMedCentral Pollack CE, et al. Racial disparities in changing to a high-volume urologist among men with localized prostate cancer. Med Care. 2011;49(11):999–1006.PubMedPubMedCentral
27.
Zurück zum Zitat Graboyes EM, et al. Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer. Cancer. 2017;123(14):2651–2660.CrossRefPubMed Graboyes EM, et al. Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer. Cancer. 2017;123(14):2651–2660.CrossRefPubMed
28.
Zurück zum Zitat Hamel LM, et al. Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control. 2016. 23(4): 327–337.CrossRefPubMed Hamel LM, et al. Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control. 2016. 23(4): 327–337.CrossRefPubMed
29.
Zurück zum Zitat Roland PY, et al. The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment. Gynecol Oncol. 2004;93(1):125–30.CrossRefPubMed Roland PY, et al. The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment. Gynecol Oncol. 2004;93(1):125–30.CrossRefPubMed
30.
Zurück zum Zitat Yokoyama Y, et al. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol Oncol. 1997;64(3):411–7.CrossRefPubMed Yokoyama Y, et al. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol Oncol. 1997;64(3):411–7.CrossRefPubMed
31.
Zurück zum Zitat Steinberg SM, et al. Comparison of risk adjustment methodologies in surgical quality improvement. Surgery. 2008;144(4):662–7 (discussion 662–7).CrossRefPubMed Steinberg SM, et al. Comparison of risk adjustment methodologies in surgical quality improvement. Surgery. 2008;144(4):662–7 (discussion 662–7).CrossRefPubMed
32.
Zurück zum Zitat Shalowitz DI, et al. Teleoncology for gynecologic cancers. Gynecol Oncol. 2015;139(1): 172–7.CrossRefPubMed Shalowitz DI, et al. Teleoncology for gynecologic cancers. Gynecol Oncol. 2015;139(1): 172–7.CrossRefPubMed
33.
Zurück zum Zitat Dafny, L. Hospital industry consolidation–still more to come? N Engl J Med. 2014;370(3):198–9.CrossRefPubMed Dafny, L. Hospital industry consolidation–still more to come? N Engl J Med. 2014;370(3):198–9.CrossRefPubMed
Metadaten
Titel
Minority Race Predicts Treatment by Non-gynecologic Oncologists in Women with Gynecologic Cancer
verfasst von
Amin A. Ramzan, MD
Kian Behbakht, MD
Bradley R. Corr, MD
Jeanelle Sheeder, MSPH, PhD
Saketh R. Guntupalli, MD
Publikationsdatum
13.08.2018
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 12/2018
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6694-0

Weitere Artikel der Ausgabe 12/2018

Annals of Surgical Oncology 12/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.